tiprankstipranks
GT Biopharma (DE:OXI)
FRANKFURT:OXI

GT Biopharma (OXI) Ownership - Who Owns GT Biopharma?

0 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Apr 11, 2023
Michael Martin Breen
Executive Chairman/interim Ceo,director
Bought$25000
Apr 10, 2023
Manu Ohri
Cfo & Secretary
Bought$25000

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,081,434Institution5,158,440
32,905Institution156,957
16,775Institution80,017
6,559Institution31,286
1,080,675Institution5,154,820
324,587Institution1,548,280

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
32,905Institution156,957
16,775Institution80,017
6,559Institution31,286
1,080,675Institution5,154,820
324,587Institution1,548,280

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns GT Biopharma (DE:OXI)?
Currently, no data Available
What percentage of GT Biopharma (DE:OXI) stock is held by institutional investors?
Currently, no data Available
What percentage of GT Biopharma (DE:OXI) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of GT Biopharma (DE:OXI)?
Vanguard owns the most shares of GT Biopharma (DE:OXI).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis